Oxygen therapy and acute respiratory failure

Oxygen is the commonest drug given in the emergency department, and it is also one of the most often misused. It is a treatment for hypoxaemia, not a panacea, and like any drug it has a target, a dose and adverse effects. The aim of emergency oxygen therapy is to correct tissue hypoxia by restoring arterial oxygen content while the underlying cause is diagnosed and treated; it is always an adjunct to, never a substitute for, definitive care. Used well it is life-saving; used carelessly it causes carbon-dioxide retention in the susceptible and lung injury at the extremes. The Fellowship-level understanding rests on three things: the physiology of oxygenation, the mechanisms by which it fails, and the devices, targets and hazards of the therapy. ^[1]

The physiology of oxygenation

Oxygen moves from the inspired gas to the mitochondrion down a cascade of partial pressures: from the dry inspired oxygen (around 21 kPa or 160 mmHg at sea level), through the humidified tracheal gas, the alveolar gas (around 13 kPa), the arterial blood (around 10 to 13 kPa), and on to the tissues. The alveolar gas equation defines the gap between the inspired and the arterial oxygen, and a widened alveolar-to-arterial gradient is the signature of a lung problem rather than a low inspired fraction or hypoventilation. Arterial oxygen content is carried almost entirely by haemoglobin — CaO2 = (1.34 x haemoglobin x saturation) plus a negligible dissolved term — which is why anaemia and saturation, not PaO2, dominate content, and why oxygen alone cannot rescue the profoundly anaemic or the carbon-monoxide-poisoned patient. The oxyhaemoglobin dissociation curve is sigmoid: above a saturation of about 90 per cent (a PaO2 of about 8 kPa) the curve is flat, so additional oxygen raises saturation little; below 90 per cent the curve is steep, so a small fall in PaO2 causes a large fall in saturation and oxygen delivery. This is why a saturation in the low 90s is a warning, not a reassurance. ^[1]

References20ShowHide

1. [1]O'Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings Thorax, 2017.PMID 28507176
2. [2]Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure N Engl J Med, 2015.PMID 25981908
3. [3]Sarkar M, Madabhavi I, Kadakol N. Oxygen-induced hypercapnia: physiological mechanisms and clinical implications Monaldi Arch Chest Dis, 2022.PMID 36412131
4. [4]Sarkar M. Mechanisms of hypoxemia Lung India, 2017.PMID 28144061
5. [5]Pilcher J, Thayabaran D, Ebmeier S, et al. The effect of 50% oxygen on PtCO(2) in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trials BMC Pulm Med, 2020.PMID 32380988
6. [6]Angelucci A, Aliverti A, Pradella I. Evaluation of the ROX index for predicting intubation in ICU patients Int J Med Inform, 2026.PMID 42361437
7. [7]Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis Lancet, 2018.PMID 29726345
8. [8]Stub D, Smith K, Bernard S, et al. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction Circulation, 2015.PMID 26002889
9. [9]Hofmann R, James SK, Jernberg T, et al. Oxygen Therapy in Suspected Acute Myocardial Infarction N Engl J Med, 2017.PMID 28844200
10. [10]Roffe C, Nevatte T, Sim J, et al. Effect of Routine Low-Dose Oxygen Supplementation on Death and Disability in Adults With Acute Stroke: The Stroke Oxygen Study Randomized Clinical Trial JAMA, 2017.PMID 28973619
11. [11]Barrot L, Asfar P, Mauny F, et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome N Engl J Med, 2020.PMID 32160661
12. [12]Franklin D, Babl FE, Schibler A, et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis N Engl J Med, 2018.PMID 29562151
13. [13]Sepehrvand N, James SK, Stub D, et al. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials Heart, 2018.PMID 29599378
14. [14]Plant PK, Owen JL, Elliott MW. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax, 2000.PMID 10856313
15. [15]Plant PK, Owen JL, Elliott MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax, 2001.PMID 11514692
16. [16]Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med, 2008.PMID 18614781
17. [17]Schjørring OL, Klitgaard TL, Perner A, et al. Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure. N Engl J Med, 2021.PMID 33471452
18. [18]Mackle D, Bellomo R, Bailey M, et al. Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med, 2020.PMID 31613432
19. [19]Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care, 2016.PMID 27481760
20. [20]Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet, 1993.PMID 8099639